Skip to content

Pilot Study of Colon Cancer Screening Tests

Randomized Comparison of Virtual Colonoscopy, Optical Colonoscopy, and Fecal Occult Blood Testing for Colorectal Cancer Screening: a Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00865527
Enrollment
198
Registered
2009-03-19
Start date
2010-03-31
Completion date
2011-09-30
Last updated
2016-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colon Cancer, Adenomatous Polyps

Keywords

Colorectal cancer, Colon cancer, Adenomatous polyps, Screening, Fecal occult blood test, Computed tomographic colonography, Colonoscopy

Brief summary

Colon cancer is the second leading cause of cancer death in North America. These deaths are preventable with proper screening. Fecal occult blood testing, virtual colonoscopy, and standard (optical) colonoscopy are all options for colon cancer screening, but it is not known which is the best at preventing death from colon cancer. A large study comparing these three tests is desperately needed. In this pilot study, the investigators want to find out what percentage of patients will show up for their screening test once enrolled. This will provide crucial information for the successful execution of the larger study.

Interventions

computed tomographic colonography

optical (conventional / endoscopic) colonoscopy

Sponsors

McMaster University
CollaboratorOTHER
Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* All individuals age 50 to 70 years

Exclusion criteria

* Unable to give informed consent * History of colorectal cancer * History of adenomatous polyp * History of inflammatory bowel disease * Prior participation in FOBT screening * Prior refusal to participate in FOBT screening * Flexible sigmoidoscopy within the previous 3 years * Virtual colonoscopy within the previous 3 years * Optical colonoscopy within the previous 3 years * Severe of terminal illness that would preclude benefit from colon cancer screening

Design outcomes

Primary

MeasureTime frame
Proportion of enrolled patients who attend for their assigned screening testImmediate

Secondary

MeasureTime frame
Proportion of patients found to have invasive colorectal carcinoma6 months
Proportion of non-responders to mailed invitations, who respond to telephone or mail reminders.Immediate
Proportion of patients requiring polypectomy after virtual colonoscopy who receive same or next day optical colonoscopy for polypectomy6 months
Proportion of subjects who cross over to another arm of the study6 months
Proportion of patients found to have an advanced adenoma6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026